Company registration number 10129514 (England and Wales)
ROADMAN HEALTH LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2024
PAGES FOR FILING WITH REGISTRAR
ROADMAN HEALTH LIMITED
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 4
ROADMAN HEALTH LIMITED
BALANCE SHEET
AS AT 30 APRIL 2024
30 April 2024
- 1 -
2024
2023
Notes
£
£
£
£
Current assets
Cash at bank and in hand
20,022
9,965
Creditors: amounts falling due within one year
3
(7,670)
(4,027)
Net current assets
12,352
5,938
Capital and reserves
Called up share capital
4
5
5
Profit and loss reserves
12,347
5,933
Total equity
12,352
5,938

For the financial year ended 30 April 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The director of the company has elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved and signed by the director and authorised for issue on 28 August 2024
Dr S C Ottman
Director
Company registration number 10129514 (England and Wales)
ROADMAN HEALTH LIMITED
NOTES TO THE  FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2024
- 2 -
1
Accounting policies
Company information

Roadman Health Limited is a private company limited by shares incorporated in England and Wales. The registered office is 4 Shadwell Park Avenue, Shadwell, Leeds, West Yorkshire, LS17 8TL.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

 

1.2
Going concern

The accounts have been prepared on the going concern basis, which assumes the continuing support of the directors and the company's ability to generate positive cash flows. In the opinion of the directors, the going concern basis is appropriate for the preparation of the accounts.true

1.3
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for the provision of medical services.

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

1.4
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.5
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

ROADMAN HEALTH LIMITED
NOTES TO THE  FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 APRIL 2024
1
Accounting policies
(Continued)
- 3 -
1.6
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

Changes in the fair value of derivatives that are designated and qualify as fair value hedges are recognised in profit or loss immediately, together with any changes in the fair value of the hedged asset or liability that are attributable to the hedged risk.

1.7
Taxation

The tax expense represents the sum of the tax currently payable.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

1.8
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

 

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2024
2023
Number
Number
Total
-
0
1
3
Creditors: amounts falling due within one year
2024
2023
£
£
Corporation tax
2,547
-
0
Other creditors
5,123
4,027
7,670
4,027
ROADMAN HEALTH LIMITED
NOTES TO THE  FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 APRIL 2024
- 4 -
4
Called up share capital
2024
2023
£
£
Ordinary share capital
Issued and fully paid
1 Ordinary A of £1 each
1
1
1 Ordinary B of £1 each
1
1
1 Ordinary C of £1 each
1
1
1 Ordinary D of £1 each
1
1
1 Ordinary E of £1 each
1
1
5
5
2024-04-302023-05-01false28 August 2024CCH SoftwareCCH Accounts Production 2024.200No description of principal activityDr S C Ottmanfalsefalse101295142023-05-012024-04-30101295142024-04-30101295142023-04-3010129514core:CurrentFinancialInstrumentscore:WithinOneYear2024-04-3010129514core:CurrentFinancialInstrumentscore:WithinOneYear2023-04-3010129514core:CurrentFinancialInstruments2024-04-3010129514core:CurrentFinancialInstruments2023-04-3010129514core:ShareCapital2024-04-3010129514core:ShareCapital2023-04-3010129514core:RetainedEarningsAccumulatedLosses2024-04-3010129514core:RetainedEarningsAccumulatedLosses2023-04-3010129514core:ShareCapitalOrdinaryShares2024-04-3010129514core:ShareCapitalOrdinaryShares2023-04-3010129514bus:Director12023-05-012024-04-30101295142022-05-012023-04-3010129514bus:PrivateLimitedCompanyLtd2023-05-012024-04-3010129514bus:SmallCompaniesRegimeForAccounts2023-05-012024-04-3010129514bus:FRS1022023-05-012024-04-3010129514bus:AuditExemptWithAccountantsReport2023-05-012024-04-3010129514bus:FullAccounts2023-05-012024-04-30xbrli:purexbrli:sharesiso4217:GBP